Clinical Trial Update: A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia [Phase 2]

View source ↗

Summary

This update reports that a Phase 2 randomized, double-blind, placebo-controlled trial of PD 0200390 in adults with primary insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• PD 0200390

Snippet

Sponsor: Pfizer | Conditions: Insomnia | Phase 2 | Status: COMPLETED